News
News Releases
xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery
Kyoto and Kanagawa, Japan, September 18, 2025 – xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery...
Nissan Chemical and Axcelead DDP Enter into Business Partnership to Support Drug Discovery Research for RNA Therapeutics
Tokyo and Kanagawa, Japan, July 18, 2025 — Nissan Chemical Corporation (HQ: Tokyo, Japan; Representative Director, President...
Axcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship
Kanagawa, Japan and Boston, MA, USA – Jun 23, 2025– Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa,...
LOTTE BIOLOGICS, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. Sign 3-Way MOU to Develop ADC Toolbox
- Exploring expansion of ADC services through synergy in ADC modality business via trilateral agreement - Aims...
Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders
December 26, 2024 - Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; “Axcelead DDP”) announced today...